FDA Investigator Kara D Dobbin

Kara D Dobbin has conducted inspections on 49 sites in 6 countries as of 02 Mar 2020. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
49
Last Inspection Date:
02 Mar 2020
Investigator Role:
FDA Investigator
Redica ID:
100008707
Countries of Inspections:
United States of America, Japan, Canada, China, India, Mexico
FDA Investigators that have inspected at least one site in common with Kara D Dobbin:
Aaron P Wozniak, Albinus M D'sa, Anthony A Charity, April R Bowen, Arsen Karapetyan, Barbara M Frazier, Benjamin E Bowen, Bonita S Chester, Brandy D Brown, Brandy N Lepage, Brittny C Cargo, Burnell M Henry, Carl A Huffman, III, Carolyn A Renshaw, CDR Ileana Barreto Pettit, CDR Thomas R Berry, PPh, Charanjeet Jassal, Charisse K Green, Chateryl K Washington, Cheryl A Clausen, Chiang Syin, PhD, Christian D Lynch (CDL), Christina L Bigham, Christopher S Keating, Christopher T Middendorf, Claire M Minden, Constantin Y Philopoulos, Crystal Monroy, Cynthia Jim, CSO, David T Glover, Dawn E Barkans, Denise M Digiulio, Devaughn Edwards, Dipesh K Shah, Dmitry Gazarian, Dongping Dai, PhD, Douglas L Page, Dr. Gang Wang, PhD, Edward D Mcdonald, Eileen J Bannerman, Ephrem Hunde, PhD, Eric S Clevenger, Esra Toussaint, Gene D Arcy, George Pyramides, Gretchen M Laws, Hai Lient Phung, Harry J Brewer, Ibad U Khan, Inga M Warr, Jacqueline D Mitchell, Jacqueline Mdiaz Albertini, James A Liubicich, James C Maclaughlin, Jared P Stevens, Jason F Chancey, Jason K Morgan, Jawaid Hamid, John D White, John E Aghadia, Johnetta F Walters, Johnson, Jonathan W Chapman, Jose A Lopez, Jose Acruz Gonzalez, Jose M Cayuela, Joseph F Owens, Justin A Boyd, Karen K Moksnes, Karen Takahashi, Kemejumaka N Opara, Kenneth H Williams, Kerry L Edwards, III, Kham Phommachanh, Lakeesha M Foster, Lareese K Thomas, Latorie S Jones, LCDR Matthew R Mcnew, MPH, REHS/RS, Lillie D Witcher, LT Daveta L Bailey, LT Tamara J Henderson, Luis Mburgos Medero, Marie A Fadden, Mark E Parmon, Marla A Cassidy, Matthew B Casale, Megan T Ziegler, Melissa J Garcia, Metitia G Sanders, Metitia M Gramby, Michael A Charles, Michael A Taylor, Miguel A Martinez Perez, Muralidhara B Gavini, PhD, Myla D Chapman, Navista C Bolton, Noreen Muñiz, Pankaj H Amin, Paul Mouris, Penny H Mccarver, Peter E Baker, Prabhu P Raju, Pratik S Upadhyay, DDC, Qin Xu, Rachael L Cook, Randy L Clarida, Reba A Gates, Robin N Goins, Roger F Zabinski, Rose Ashley, Rose Xu, Samuel L Murray, Sandra I Gaul, Santos E Camara, Satheesh Thomas, Sena G Dissmeyer, Seneca D Toms, Sharna D Pratt, Shelby N Turner, Sherry R Dunn, Simone E Pitts, Sixto M Mercado Rios, Song Y Lavalais, Stacey S Degarmo, Stephen J Koniers, Steven D Kehoe, Steven J Rush, Susan M Jackson, Susan O Oladeji, Susanne M Richardson, MS RAC, Tajah L Blackburn, Tamika D Cathey, Tekalign Wondimu, Teresa I Navas, Thomas W Gordon, Timothy T Kapsala, Tracy R Ball, Travis R Hunt, Veronica Fuentes, MS, Vicky C Stoakes, Vincent M Williams, Viviana Matta, William P Tonkins, Yvette I Johnson, Zedong Dong, Zhong Li, PhD

Kara D Dobbin's Documents

Publish Date Document Type Title
January, 2019 FDA 483 Zhejiang Dingtai Pharmaceutical Co., Ltd - Form 483, 2019-01-25
June, 2016 EIR Fresenius Kabi USA, LLC - EIR, 2016-06-24
June, 2016 FDA 483 Fresenius Kabi USA, LLC - Form 483, 2016-06-24
July, 2018 FDA 483 Symrise, S. DE R.L.DE C.V. - Form 483, 2018-09-21
March, 2020 FDA 483 Lifequest Creations LLC - Form 483, 2020-03-09
June, 2019 FDA 483 AGON PHARMA PRIVATE LIMITED - Form 483, 2019-06-13
February, 2017 FDA 483 ASANUMA CORPORATION - Form 483, 2017-02-02
July, 2017 FDA 483 Quality Chemical Laboratories - Form 483, 2017-07-27
June, 2017 EIR WINDER LABORATORIES, LLC - EIR, 2017-06-09
January, 2017 FDA 483 KATAYAMA SEIYAKUSYO CO., LTD. - Form 483, 2017-01-26
February, 2020 FDA 483 Scapa Tapes North America Llc - Form 483, 2020-02-07
March, 2017 FDA 483 The Procter & Gamble Manufacturing Company - Form 483, 2017-03-10
November, 2019 EIR Formulated Solutions Cleveland, LLC - EIR, 2019-11-15
July, 2017 EIR Quality Chemical Laboratories - EIR, 2017-07-27
April, 2018 FDA 483 Choksi Laboratories Limited - Form 483, 2018-04-25
January, 2017 FDA 483 Kyowa Pharma Chemical Co., Ltd. - Form 483, 2017-01-20

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more